Marzetti

MZTI on Nasdaq. The Marzetti Company sells specialty food products to retail and foodservice customers. Market value $2.7bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to June 2026.

Should I look at this?

Worth a closer look

Read what could go wrong

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to June 2026
7.5%high

For every $100 of what the whole company costs, it produced $7.54 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to June 2026
12.2×fair

You pay 12.2 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to June 2026
n/a

The filings do not give us enough to work this out.

Quality score: 80 of 100. Price score: 99 of 100. Our list needs 70 on quality and 60 on price.

$100.20 a share, 3% above its 1-year low

Over the past year the price has ranged from $97.00 to $176.26.

Dividend: 4.0% a year

Paid every year for at least 5 years

Prices from Tuesday’s close (6 October).

Five years of cash, in billions

-0.0
0.1
0.2
0.2
0.2
20222023202420252026
Revenue
$1.7bn$1.8bn$1.9bn$1.9bn$1.9bn
Operating margin
6.7%7.8%10.7%11.5%12.4%
Debt to equity
n/an/an/a0.000.20
Shares outstanding
0.03bn0.03bn0.03bn0.03bn0.03bn

Health checks

  • Free cash flow positive4 of 5 years
  • Accounting looks honest (Beneish)Nothing unusual
  • Financial strength (Piotroski)6 of 9
  • Profit backed by cash (accruals)Yes
  • Debt0.20× equity
  • Revenue growth, five yearsSlow, 5.6% a year
  • Buying back its own sharesRoughly flat

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $465 million last quarter, down 2% on a year ago.
  • Profit: $48 million, up 48% on a year ago.
  • It keeps 12 cents of each $1 of sales as operating profit, about the same as a year earlier.
  • Spare cash over the past 12 months: $206 million, up from $203 million.
  • Debt is $185 million more than cash. A year ago it had $160 million more cash than debt.
  • Sales grew on a year ago in 2 of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$467m
December 2024$509m
March 2025$458m
June 2025$475m
September 2025$493m
December 2025$518m
March 2026$453m
June 2026$465m
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024$45m
December 2024$49m
March 2025$41m
June 2025$33m
September 2025$47m
December 2025$59m
March 2026$37m
June 2026$48m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
25 August 2026
Next quarterly (estimated, 10-Q)
3 August 2026

Who owns it

3 long-term investors we follow own it, unchanged from 3 last quarter. 334 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

2 investors own more than 5%.

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 1 insider bought $98,109 of shares on the open market. 1 sold $233,980.

  • Viso Luis
    Strategic Advisor to CEO
    Sold
    Date
    10 September 2026
    Shares
    997
    Price
    $100.81
    Value
    $100,512
  • Viso Luis
    Chief Supply Chain Officer
    Sold
    Date
    11 June 2026
    Shares
    1,221
    Price
    $109.31
    Value
    $133,468
  • Pigott, Thomas K.
    VP, CFO and Asst. Secretary
    Bought
    Date
    10 June 2026
    Shares
    900
    Price
    $109.01
    Value
    $98,109

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 25 Aug 2026, and no later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

Cheap for a reason is the question the numbers cannot answer.

Whether the price already reflects the risks is what the deep dive is for.

What changed in the risks this year

Companies must list what could hurt them each year. These are the parts that changed since last year’s report.

  • We may not realize the anticipated benefits of our acquisition of Bachan’s, Inc., and the integration of the acquired business may disrupt our operations, divert management attention, or result in unanticipated costs or liabilities.

    Could happen
    On May 1, 2026, we acquired Bachan’s, Inc. (“Bachan’s”) for approximately $400 million, subject to customary adjustments, in a transaction funded through a combination of cash on hand and borrowings under our credit facility. As the largest acquisition in our history, the success of this transaction depends on our ability to effectively integrate Bachan’s operations, products and personnel and to achieve the anticipated strategic and financial benefits.
    Read more
  • Our Credit Agreement requires us to comply with certain restrictive covenants that impose restrictions on our operations, which could adversely affect our business.

    Could happen
    An increase in interest rates would have an adverse effect on our results of operations, as we have exposure to variable interest rates tied to SOFR or an alternate base rate defined in the Credit Agreement.
  • Our Credit Agreement requires us to comply with certain restrictive covenants that impose restrictions on our operations, which could adversely affect our business.

    Could happen
    Our Credit Agreement also contains customary events of default, including failure to comply with certain financial and other covenants. Upon a default that is not cured or waived within the applicable cure period, our outstanding obligations may be accelerated, in addition to other remedies that are available to our lenders. If the lenders accelerate payment of indebtedness, our assets may not be sufficient to repay in full our indebtedness, and we may need to reduce or curtail uses of cash, including dividend payments, share repurchases, acquisitions, or capital expenditures, which could limit our ability to respond to market conditions, pursue strategic opportunities, or otherwise conduct our operations.
    Read more
  • Our Credit Agreement requires us to comply with certain restrictive covenants that impose restrictions on our operations, which could adversely affect our business.

    Could happen
    Additionally, our capital resources may not be sufficient to satisfy our liquidity needs, and we may seek to obtain additional debt financing, which would result in increased expenses. We may not be able to obtain additional financing, if required, in amounts or on terms acceptable to us, or at all. If we are not able to obtain additional financing, we may be required to reduce discretionary spending; delay strategic initiatives; seek additional financing on less favorable terms; or take other actions to meet our liquidity needs. Any such developments could have a material adverse effect on our business, financial condition, results of operations, and cash flows.
    Read more
  • We may not realize the anticipated benefits of our acquisition of Bachan’s, Inc., and the integration of the acquired business may disrupt our operations, divert management attention, or result in unanticipated costs or liabilities.

    Could happen
    The integration process may be more difficult, costly, or time-consuming than expected and could result in the loss of key employees whose expertise and relationships were central to the brand's pre-acquisition growth, challenges in maintaining the strength and growth of the Bachan’s brand, operational or supply chain disruptions including those in connection with introductions of new products or new contract manufacturers, failure to achieve projected cost synergies, the diversion of management's attention from other business priorities, and the incurrence of significant integration, transaction, or other costs and liabilities that were not anticipated. In addition, Bachan’s future growth rates may not meet our expectations, which could adversely affect our ability to generate expected returns on the acquisition and lead to impairment charges related to the intangible assets recorded in connection with the transaction.
    Read more

Read it in the annual report

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.